Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study - Budde, Lihua E.; Sehn, Laurie H; Matasar, Matthew; Schuster, Stephen J; Assouline, Sarit; Giri, Pratyush; Kuruvilla, John; Canales, Miguel; Dietrich, Sascha; Fay, Keith; Ku, Matthew; Nastoupil, Loretta; et al. (The lancet. Oncology, 2022)
Gesehen am 13.02.2023